Jacob Raber Selected Research

Apolipoprotein E2

1/2019	Correction: ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.
9/2015	ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.
12/2006	Sex- and APOE isoform-dependent effects of radiation on cognitive function.
8/2005	Role of circulating androgen levels in effects of apoE4 on cognitive function.
6/2002	Androgens protect against apolipoprotein E4-induced cognitive deficits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacob Raber Research Topics

Disease

31	Cognitive Dysfunction 01/2022 - 06/2002
24	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 06/2002
12	Neoplasms (Cancer) 01/2022 - 01/2010
5	Body Weight (Weight, Body) 01/2022 - 01/2017
5	Wounds and Injuries (Trauma) 01/2022 - 01/2012
5	Inflammation (Inflammations) 01/2021 - 06/2013
5	Dementia (Dementias) 01/2021 - 05/2006
5	Insulin Resistance 01/2020 - 01/2017
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2015 - 01/2006
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2022 - 01/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2016
4	Shock 06/2016 - 06/2011
3	Neuroinflammatory Diseases 08/2022 - 07/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 09/2015
3	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2021
3	Obesity 01/2020 - 12/2018
3	Anxiety Disorders (Anxiety Disorder) 04/2015 - 10/2010
3	AIDS-Related Complex (ARC) 01/2012 - 10/2006
2	Carcinogenesis 01/2022 - 01/2020
2	Phenylketonurias (Phenylketonuria) 01/2022 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 10/2007
2	Memory Disorders (Memory Loss) 01/2017 - 06/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2014
2	Brain Injuries (Brain Injury) 01/2015 - 02/2013
2	Seizures (Absence Seizure) 08/2008 - 10/2006
2	Androgen-Insensitivity Syndrome (Testicular Feminization) 04/2008 - 02/2005
1	Chest Pain (Chest Pains) 09/2021
1	Pathologic Constriction (Stenosis) 09/2021
1	Postoperative Cognitive Complications 01/2021
1	Synucleinopathies 01/2021
1	Infections 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Multiple System Atrophy 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Weight Loss (Weight Reduction) 11/2020
1	Anorexia 11/2020
1	Fatigue 09/2018

Drug/Important Bio-Agent (IBA)

18	Apolipoproteins E (ApoE)IBA 08/2022 - 03/2004
15	Apolipoprotein E4IBA 01/2020 - 06/2002
13	ApolipoproteinsIBA 08/2022 - 06/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
8	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2006
8	Apolipoprotein E3IBA 01/2021 - 06/2002
5	salicylhydroxamic acid (SHAM)IBA 01/2020 - 05/2009
5	Apolipoprotein E2IBA 01/2019 - 06/2002
4	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2017
4	AndrogensIBA 03/2011 - 06/2002
3	Insulin (Novolin)FDA Link 08/2022 - 07/2005
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2003
3	metabotropic glutamate receptor 8IBA 01/2021 - 07/2005
3	xanthohumolIBA 01/2021 - 12/2018
3	Protons (Proton)IBA 01/2016 - 02/2015
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 09/2015
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2011
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 10/2010
2	alpha-SynucleinIBA 01/2021 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2015
2	SugarsIBA 01/2020 - 01/2019
2	FlavonoidsIBA 01/2020 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 09/2018
2	CholesterolIBA 09/2018 - 02/2013
2	IonsIBA 06/2016 - 03/2012
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2016 - 10/2011
2	Biological ProductsIBA 09/2015 - 01/2006
2	Eflornithine (Ornidyl)FDA Link 11/2014 - 01/2012
2	ChemokinesIBA 07/2013 - 06/2013
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2011 - 10/2007
2	Androgen Receptors (Androgen Receptor)IBA 03/2011 - 02/2005
2	Cholinergic Agents (Cholinergics)IBA 01/2011 - 08/2008
2	Amyloid beta-PeptidesIBA 05/2006 - 08/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2022
1	pegvaliaseIBA 01/2022
1	regadenoson FDA Link 09/2021
1	Protein AggregatesIBA 01/2021
1	CarbonIBA 01/2021
1	LipidsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	PrionsIBA 01/2021
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	EphrinsIBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 11/2020
1	CeramidesIBA 01/2020
1	SphingolipidsIBA 01/2020
1	FatsIBA 01/2019
1	Estrogens (Estrogen)FDA Link 12/2018
1	LDL CholesterolIBA 09/2018
1	LeptinIBA 09/2018
1	Triglycerides (Triacylglycerol)IBA 09/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2018
1	CytokinesIBA 02/2017

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2010
2	Radiotherapy 11/2021 - 02/2017
2	Fat-Restricted Diet (Diet, Fat Restricted) 09/2018 - 01/2016
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020
1	African Traditional Medicine (Medicine, African) 09/2018
1	Immunotherapy 02/2017